Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Can money buy happiness? The relationship between money and well-being

  • Finding psychological insights through social media

  • How does the human brain tackle problems it did not evolve to solve?

  • Patient perceptions of physician compassion measured

  • Reviving drugs with anti-stroke potential, minus side effects

  • Intimate partners with low self-esteem stay in unhappy relationships

  • New compounds protect nervous system from the structural damage characteristic of multiple sclerosis

  • Shake it off? Not so easy for people with depression, new brain research suggests

  • Introverts prefer mountains

  • Research of plain wren duets could help further understand fundamentals of conversation

  •